IVD Clarithromycin, Quinolone-Resistant and Non-Resistant Helicobacter Pylori Nucleic Acid Amplification Test Kit Fluorescent Probe-Based Real-Time PCR Assay Why do we test Helicobacter Pylori? About 50% of people in the world have a history of Helicobacter Pylori infection; The Maastricht V/Florence Consensus Report pointed out “H. pylori infection is accepted as the major aetiological factor for gastric cancer, and H. pylori eradication reduces the risk of gastric cancer development.” Why is it important to detect Helicobacter pylori antibiotic resistance? Due to the extensive use of antibiotics, H pylori resistance strains are widespread; The Maastricht V/Florence Consensus Report recommended performing clarithromycin susceptibility testing by the molecular test directly on the gastric biopsy specimen. Test Principle This kit uses polymerase chain reaction (PCR) based on TaqMan fluorescent probe technology to identify H. pylori and antibiotic-resistant mutations from human gastric gastric biopsy specimen

Comparison of eradication rate with susceptible strains and resistant strains after 14 days treatment. Treatment Protocol Susceptible strains CAM and/or LVX Resistant strains Standard Triple therapy Levofloxacin triple therapy Bismuth quadruple therapy Once the infected H.pylori are resistant strains, our products can help: Selection of effective antibiotics and treatment protocol to increase the eradication rate. Avoid secondary antibiotic resistance due to the first treatment failure. Reduce H. pylori diagnosis cost and save treatment time. Avoid multiple eradications leading to the extinction...